Does SOC typically not fix the myocardial dysfunction associated with MIS-C?
Not with these children. Also, 50 plus children died from MIS-C. I would like to see the data!
The people paid by MSB are experts in their respective field. The regulatory authority and doctors around the world should take note.
My argument is, rem_L is safe and has shown to work in certain people, why not use it as an Emergency? just like so many other products that get the green light.
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-146
-
- There are more pages in this discussion • 278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |